137 related articles for article (PubMed ID: 16928940)
1. Percutaneous radiofrequency ablation of ovarian cancer metastasis to the liver: indications, outcomes, and role in patient management.
Gervais DA; Arellano RS; Mueller PR
AJR Am J Roentgenol; 2006 Sep; 187(3):746-50. PubMed ID: 16928940
[TBL] [Abstract][Full Text] [Related]
2. Optimal cytoreduction after combined resection and radiofrequency ablation of hepatic metastases from recurrent malignant ovarian tumors.
Mateo R; Singh G; Jabbour N; Palmer S; Genyk Y; Roman L
Gynecol Oncol; 2005 Apr; 97(1):266-70. PubMed ID: 15790474
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation in the management of liver metastases from breast cancer.
Sofocleous CT; Nascimento RG; Gonen M; Theodoulou M; Covey AM; Brody LA; Solomon SM; Thornton R; Fong Y; Getrajdman GI; Brown KT
AJR Am J Roentgenol; 2007 Oct; 189(4):883-9. PubMed ID: 17885061
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation of liver metastasis from ovarian adenocarcinoma: case report and literature review.
Bojalian MO; Machado GR; Swensen R; Reeves ME
Gynecol Oncol; 2004 May; 93(2):557-60. PubMed ID: 15099981
[TBL] [Abstract][Full Text] [Related]
5. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
6. [Radiofrequency ablation in primary and secondary liver tumors].
Carditello A; Scisca C; David A; Stilo F; Basile M
Chir Ital; 2002; 54(1):83-6. PubMed ID: 11942016
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
8. Hepatic radiofrequency ablation of metastatic ovarian granulosa cell tumors.
Jacobs IA; Chang CK; Salti G
Am Surg; 2003 May; 69(5):416-8. PubMed ID: 12769214
[TBL] [Abstract][Full Text] [Related]
9. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation for unresectable tumors of the liver.
Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
[TBL] [Abstract][Full Text] [Related]
11. The possible role of radiofrequency as complementary treatment of locally advanced gastric cancer.
Carditello A; Scisca C; Stilo F; Parisi A; Basile M
Ann Ital Chir; 2005; 76(1):39-41. PubMed ID: 16035670
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 patients.
Kettenbach J; Köstler W; Rücklinger E; Gustorff B; Hüpfl M; Wolf F; Peer K; Weigner M; Lammer J; Müller W; Goldberg SN
AJR Am J Roentgenol; 2003 Jun; 180(6):1537-45. PubMed ID: 12760914
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency thermal ablation (RFA) of liver tumors: percutaneous and open surgical approaches.
Crucitti A; Danza FM; Antinori A; Vincenzo A; Pirulli PG; Bock E; Magistrelli P
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):191-5. PubMed ID: 16767930
[TBL] [Abstract][Full Text] [Related]
14. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients.
Lorentzen T; Skjoldbye BO; Nolsoe CP
Ultraschall Med; 2011 Oct; 32(5):492-6. PubMed ID: 21259183
[TBL] [Abstract][Full Text] [Related]
15. [Ultrasound-guided assistant infusion technique for percutaneous radiofrequency ablation of liver cancer].
Han Y; Hao YZ; Cai JQ; Yang M; Liu S; He LF; Yu L; Chen MH
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):266-9. PubMed ID: 22964146
[TBL] [Abstract][Full Text] [Related]
16. Complications after percutaneous saline-enhanced radiofrequency ablation of liver tumors: 3-year experience with 336 patients at a single center.
Giorgio A; Tarantino L; de Stefano G; Coppola C; Ferraioli G
AJR Am J Roentgenol; 2005 Jan; 184(1):207-11. PubMed ID: 15615976
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
[TBL] [Abstract][Full Text] [Related]
18. [Percutaneous radiofrequency ablation of hepatic metastases. Preliminary experience].
De Baere T; Elias D; Ducreux M; Dromain C; Kuach V; Gamal El Din M; Sobotka A; Lasser P; Roche A
Gastroenterol Clin Biol; 1999 Nov; 23(11):1128-33. PubMed ID: 10651531
[TBL] [Abstract][Full Text] [Related]
19. Results of liver resection in combination with radiofrequency ablation for hepatic malignancies.
Eisele RM; Zhukowa J; Chopra S; Schmidt SC; Neumann U; Pratschke J; Schumacher G
Eur J Surg Oncol; 2010 Mar; 36(3):269-74. PubMed ID: 19726155
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation of liver cancer.
Lencioni R; Crocetti L
Tech Vasc Interv Radiol; 2007 Mar; 10(1):38-46. PubMed ID: 17980317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
